Researchers used artificial intelligence to design entirely synthetic viruses. These lab-created entities mimic natural viral structures to study infection mechanisms without using live pathogens. The team focused on protein folding and genomic sequencing to ensure stability. This approach allows scientists to test vaccines and antiviral drugs against precise, engineered targets without risking natural outbreaks.